UK-CAB 82: Glasgow conference feedback, Gilead Sciences, RIO study update
Date: 11 November 2022
Venue: Room MAL 252, Malet Street, Torrington Square, London WC1E 7HX
Directions from Russell Square tube station
Programme:
09.15-09.30 | Arrival, expenses, tea and refreshments |
09.45-10.00 | Welcome and introductions UK-CAB updates Company pre-meeting |
10.00-11.00 | Glasgow conference feedback: – Conference highlights: Alex Sparrowhawk, UK-CAB – Cure research update: Memory Sachikonye, UK-CAB |
11.00-11.15 | BREAK |
11.15-12.45 | Company meeting: Gilead Sciences |
12.45-14.00 | LUNCH |
14.00-14.45 | RIO study update – Ming Lee, Imperial College |
14.45-15.30 | IAS feedback, Roger Pebody, NAM |
15.30-15.45 | BREAK |
15.45-16.30 | Members updates; Meeting reflection |
16.30-17.00 | Any other business and meeting close |
Presentations from the meeting:
– Glasgow Conference highlights: Alex Sparrowhawk
– Cure research update: Memory Sachikonye
– RIO Study update: Ming Lee
– IAS feedback: Roger Pebody
Background reading:
Funding
- Since 2011, i-Base provide admin support to the UK-CAB. Other costs are covered by grants to the UK-CAB. This includes support from drug companies for meetings.
- Training courses are funded by specific grants, including from the Lottery Fund.
- From 2008-2011 the CAB was supported by the Monument Trust. This allowed us to employ a part-time administrator.
- From 2002 to 2008, running costs for the UK-CAB were supported by i-Base. Drug companies funding meeting costs.
We have always asked HIV drug companies to support the direct costs for UK-CAB meetings.
This covers travel and accommodation for members coming from out of London. It also covers the cost of catering. This industry funding helps support the CAB as a national project. A list of supporting companies since the UK-CAB was established in 2002 and from the most recent years is included below. 3
The UK-CAB membership and Steering Group decides the content for all meetings.
Meetings with a drug company covers their current products and future research. The decision for which companies to invite and the agenda for these meetings is made by the UK-CAB.
We also ask other researchers to involve the UK-CAB in planning studies and ongoing research. We ask that community involvement in research be included in the budget of grant proposals so that some of the CAB work can be supported in this way by independent research.